Blue Owl Capital Holdings’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Blue Owl Capital Holdings’s Portfolio SYRS Stock Details SYRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell
2024 Q3	$1.11M	Buy
2024 Q2	$1.76M	Hold
2024 Q1	$1.82M	Sell
2023 Q4	$8.46M	Buy